ECR-62593-46090
3 vaccinations
7 coded responses
44 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 958 / CA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
39M-62880-53936
Child or adolescent in my care · Male · 2022-06-30
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Joint pains, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-06-18
Survey response — 3 months, dose 1MedDRA: Neuralgia — Feeling: GoodFree text: Leg nerve painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-17
-
2021-10-28
Dose 2 — Moderna
- 2021-10-28
-
2021-10-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
-
2021-12-02
Survey response — day 35, dose 2MedDRA: Nasal congestion — Feeling: GoodFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-09
-
2022-01-27
Survey response — 3 months, dose 2MedDRA: Chills, Cough, Fatigue, Pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, fever, runny nose, fatigue, chills, body achesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-28
Survey response — 6 months, dose 2MedDRA: COVID-19, Chest pain, Dizziness, Dyspnoea, Fatigue, Post-acute COVID-19 syndrome, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: COVID infection - tested positive 2/16/22. Post COVID syndrome. Shortness of breath, extreme fatigue, dizziness, chest pain.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-28
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-03
Dose 3 — Moderna
-
2022-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Joint painsAdult check-in
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
-
2022-10-17
Survey response — day 14, dose 3MedDRA: Sinusitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-18
-
2022-10-18
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-24
-
2022-10-31
Survey response — day 28, dose 3MedDRA: Fatigue, Nausea, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Nausea, congestion, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-11-07
- 2022-11-14
-
2023-01-02
Survey response — 3 months, dose 3MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-02
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-28 | Moderna | No |
| 3 | 2022-10-03 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 9 — 3 months, dose 1
Symptoms: Leg nerve pain
Release 10 — day 35, dose 2
Symptoms: Stuffy nose
Release 11 — 3 months, dose 2
Symptoms: Cough, fever, runny nose, fatigue, chills, body aches
Release 11 — 6 months, dose 2
Symptoms: COVID infection - tested positive 2/16/22. Post COVID syndrome. Shortness of breath, extreme fatigue, dizziness, chest pain.
Release 12 — day 14, dose 3
Symptoms: Sinus infection
Release 12 — day 28, dose 3
Symptoms: Nausea, congestion, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Neuralgia | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release